News
-
Stanford University’s Innovative Medicines Accelerator and Intonation Research Laboratories form a collaboration to fight cancerous neuroendocrine tumors
The goal of the collaboration is to rapidly improve care for patients with tumors that form from hormone-releasing cells.
June 22, 2023
-
From Our Neurons to Yours Podcast: Exercise and the Brain
Institute Scholar Jonathan Long discusses his recent discovery of a new molecule produced when we exercise that appears to be linked to health benefits.
June 22, 2023
-
Carolyn Bertozzi named 2024 Priestley medalist
The award recognizes Bertozzi's development of bioorthogonal chemistry and service to chemistry community.
June 20, 2023
-
Institute Scholar Steven Banik named a 2023 Beckman Young Investigator
Researchers including our Institute Scholar Steven Banik were selected to receive $6.6M in science funding for cutting-edge research.
June 14, 2023
-
Understanding how different cell types respond to exercise could be key step toward exercise as medicine
Institute Scholar Jonathan Long and team’s new research explores how exerkines could one day be used as medicine to treat obesity, heart disease, diabetes, and more.
June 14, 2023
-
Institute Scholars Steven Banik and Christopher Barnes named 2023 Pew Biomedical Scholars
Steven Banik and Christopher Barnes named Pew Biomedical Scholars for their work aiming to optimize delivery of therapeutic drugs for diseases and combat spread of coronaviruses.
June 13, 2023
-
Brain cancer specialists hope Biden’s Moonshot speeds therapies
Researchers including Institute Scholar Paul Mischel gathered in Washington D.C. for President Biden's Cancer Moonshot initiative that aims to cut death rate from cancer.
June 12, 2023
-
CBI trainee Mekedlawit Setegne recognized as recipient of 2023 DARE Fellowship
The DARE Doctoral Fellowship Program awards two-year fellowships to advanced Stanford doctoral students who want to investigate and prepare for academic careers.
May 19, 2023
-
Celebrating a decade of interdisciplinary and innovative research to advance human health
The 10-Year Sarafan ChEM-H Symposium featured opening remarks from Carolyn Bertozzi, keynote address by David Baker, research talks from the community, and more.
May 12, 2023
-
Carolyn Bertozzi: Nobel Prize Conversations
Meet chemist and 2022 Nobel Prize laureate Bertozzi. In this episode she speaks about her two life-long loves: organic chemistry and music.
May 10, 2023
-
Meet the Scientific Misfits
Sarafan ChEM-H in collaboration with partner departments has recruited and hired 17 faculty members, known as Institute Scholars, who are tackling interdisciplinary problems.
May 01, 2023
-
Meet the immune system wranglers
Our Institute Scholars are untangling the immune system’s molecular and physical triggers to create novel vaccines and therapies.
May 01, 2023
-
Meet the emerging disease fighters
Our Institute Scholars are discovering complexities of our immune system to pioneer new anti-infectives.
May 01, 2023
-
Meet the molecular trackers
Our Institute Scholars are uncovering links between metabolism and health and discovering new ways to treat metabolic disorders.
May 01, 2023
-
Meet the cancer drug hunters
Our Institute Scholars are digging deeper into cancer’s biology to create next generation therapies.
May 01, 2023
-
Meet the tool builders
Our Institute Scholars are developing molecular and biophysical tools to advance understanding of cell mechanisms and their contribution in diseases.
May 01, 2023
-
Durable, low-cost COVID-19 vaccine could help fill in gaps around the world
In a study led by Institute Scholar Peter Kim, a low-cost COVID-19 vaccine that does not require refrigeration provided immunity in rhesus monkeys for one year.
April 17, 2023
-
Researchers use skin-colonizing bacteria to create a topical cancer therapy in mice
In a study led by Institute Scholar Michael Fischbach, researchers harnessed the skin’s immune response to bacteria to create an immunotherapy — delivered by swab — that treats agg
April 12, 2023
-
Tiny DNA circles are key drivers of cancer, Stanford Medicine-led international study finds
Tiny circles of DNA harbor cancer-associated oncogenes and immunomodulatory genes promoting cancer development. They arise during transformation from pre-cancer to cancer.
April 12, 2023
-
Institute Scholar Stanley Qi elected into AIMBE
Stanley Qi has been elected to the AIMBE College of Fellows for his contributions to the development and dissemination of genome editing techniques.
March 27, 2023